Email
Password

Forgot Password?


Course Overview

The NLA's Foundations of Lipidology Course provides a comprehensive, in-depth instoruction to lipid science and is open to all health care professionals interested in developing a core competency in the diagnosis and treatment of dyslipidemia. The interactive Lipid Academy course provides health professionals with the knowledge and tools necessary to work effectively in a lipid practice, and will serve as a preparatory course for the Annual Scientific Forum and other advanced lipid training.

This version of the NLA Foundations of Lipidology is offered as a 14.5-hour online course.

Course Curriculum

  • Atherosclerosis, Lipids and Lipoproteins, Atherogenic Dyslipidemia
  • Current Lifestyle Recommendations
  • Pharmacologic Therapies
  • Landmark Clinical Trials
  • Overview of Clinical Guidelines in Lipid Management
  • Lipid Management of Specific Populations
  • Dyslipidemia and Inherited Lipid Disorders
  • 3 Complex Case Presentations

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, advance practice registered nurses, nurse practitioners and registered dietitians with an interest in lipid management.

System Requirements

To view this educational activity you will need a JavaScript enabled web browser (Google Chrome, Firefox or Microsoft Edge or Safari on Mac recommended) with Browser Cookies enabled. Both Android and iOS tablet devices are supported. Handheld formats may work; but are not optimal and not officially supported. These courses are optimized for desktops, laptops, and tablets. For optimal viewing experience, we recommend using a desktop computer, laptop, and larger tablets. NLA does not guarantee user experience on handheld devices.

Objectives and Accreditation

PROGRAM OVERVIEW

The NLA's Foundations of Lipidology course provides an introductory review of the core curriculum in Clinical Lipidology. This course is designed for any healthcare professional seeking to learn the fundamentals of Lipidology. Experts in Lipidology will lecture on basic concepts and guide participants through interactive learning scenarios that provide the knowledge and tools necessary to work effectively in a lipid practice and prepare for advanced training.

This course is particularly useful to review core elements of Clinical Lipidology and is appropriate for clinicians from the full spectrum of clinical experience including Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Exercise Physiologists, and Dietitians who are in any phase of training, or even experienced physicians who are looking to take a deeper dive into Lipidology.

ACTIVITY TYPE

Enduring Internet Activity

NLA Activity ID: 2025019

ACTIVITY DATES

Release Date: April 4, 2025
Expiration Date: April 4, 2028

FEE INFORMATION

This course offered to NLA members at a cost of $550.
All other participants may purchase this course at a cost of $950.

TARGET AUDIENCE

This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, advance practice registered nurses, nurse practitioners and registered dietitians seeking to develop an expertise in clinical lipidology.

LEARNING OBJECTIVES

At the conclusion of this activity, participants should be able to:

  • Explain the pathogenesis of atherosclerosis, including the role of inflammation;
  • Describe the functions and sources of cholesterol and triglycerides including the role of lipoproteins in atherosclerosis;
  • Review basic principles of statistics in clinical trials;
  • Discuss key clinical trials of lipid-altering drug therapies used in cardiovascular disease prevention;
  • Recognize the role of drug therapy in the management of dyslipidemia;
  • Review the mechanism of action, pharmacokinetics, and efficacy of approved drugs for the management of dyslipidemia;
  • Review types of pharmacotherapy with lipid-related impacts;
  • Council patients on dietary recommendation for lipid management;
  • Recognize the importance of lifestyle modification in the reduction of cardiometabolic risk;
  • Describe treatment approaches for dyslipidemia in specific populations based on age, gender, ethnicity, and cultural variables;
  • Discuss current guidelines for the management and treatment of patients with dyslipidemia;
  • Identify primary and secondary causes of dyslipidemia;
  • Recognize comorbidities associated with and causes of secondary dyslipidemias.
  • Distinguish between acquired and inherited dyslipidemias.
  • Compose a treatment plan for patients with complex lipid disorders;
  • Compose a treatment plan for the management of dyslipidemia in specific populations;
  • Compose a treatment plan for reducing risk of CVD in patients with dyslipidemia.

CRITERIA FOR SUCCESS

Statements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form. Partial credit may be awarded for ACPE credit. A statement of credit will be available upon completion of this course. The deadline to claim credit is April 4, 2026.

For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

*IMPORTANT* Pharmacists MUST request credit before April 15, 2026. Credit requested after this date will be subject to a fee by the accreditation board.

For Dietitians: Upon completion of the activity evaluation form, dietitians may submit evaluations of the quality of activities/materials to CDR. Poor evaluations of activities/materials may trigger an audit of the activities/ materials by CDR.

COMMERCIAL SUPPORT

This educational activity has been provided with support by an educational grant from Novartis.

CREDIT DESIGNATION

abim Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.5 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Jointly Accredited Provider

CME credit provided by the National Lipid Association
In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement
The National Lipid Association designates this Enduring Internet activity for a maximum of 14.5 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 14.5 continuing professional education units (CPEUs) for completion of this program/materials.

Pharmacists
Accreditation Council for Pharmacy Education Universal Activity Number – JA0007192-0000-25-012-H01-P (Application)
This Activity has been approved for 14.5 contact hour(s) (1.45 CEUs) of the Accreditation Council for Pharmacy Education.

Nursing
The maximum number of hours awarded for this CE activity is 14.5 contact hours.

For the advanced practice nurse, this activity has 4 contact hours of pharmacotherapy content.

PROGRAM CO-CHAIRS

Joseph J. Saseen, PharmD, BCPS, BCACP, MNLA*
Professor and Vice Chair
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado
Anschutz Medical Campus
Aurora, CO

Daniel E. Soffer, MD, FNLA*
University of Pennsylvania Health System
Internal Medicine/Clinical Lipidology
Perelman Center for Advanced Medicine
Philadelphia, PA

FACULTY

Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA*
Clinical Scientist, Midwest Biomedical Research
Addison, IL
Adjunct Faculty, Kasiska Division of Health Sciences
Idaho State University
Pocatello, ID

Ann Liebeskind, MD, FNLA*
Founder, Mobile Health Teams Lipids Clinic
Neenah, WI
Clinical Adjunct Assistant Professor of Medicine
University of Wisconsin
School of Medicine and Public Health
Madison, WI

*Denotes Diplomate, American Board of Clinical Lipidology (ABCL)


FACULTY/PLANNER FINANCIAL DISCLOSURES

Speaker
Relationship
Company

Kirkpatrick, Carol
N/A
Nothing to Disclose

Liebeskind, Ann
N/A
Nothing to Disclose

Saseen, Joseph
Monitoring Committee
Amgen

Soffer, Daniel
Advisor Committee/Consultant
Amgen, Amryt, Endless Health, Genincode, Heartflow, Ionis, PHAR, New Amsterdam, Regeneron
Investigator
Akcea, Amgen, Amryt, Arrowhead, Ionis, Lilly, Novartis, PCORI, NIH, Heartflow

NLA
N/A
The National Lipid Association Staff has nothing to disclose


DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCTS

This educational activity may include discussion of the uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLOSURE DECLARATION

It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all its continuing education activities. Planners, faculty, reviewers, and staff have disclosed any financial relationships with commercial interests as defined by the ACCME. All disclosures have been reviewed and resolved at this time.

DISCLAIMER

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.

PERMISSIONS

The National Lipid Association acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.

Please enter your business email address. We will email you a link that will allow you to select a new password.

Please enter your business email address to start your registration.